Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer

Diletta Di Mitri, Alberto Toso, Jingjing Chen, +14

Nature

Tumor BiologyMedicineCancer Cell BiologyCellular SenescenceCancer Biology +4

Risk of Prostate Cancer-Specific Mortality Following Biochemical Recurrence After Radical Prostatectomy

Stephen J. Freedland, Elizabeth B. Humphreys, Leslie A. Mangold, +4

The Journal of Urology

Surgical OncologyEpidemiology Of CancerPopulation Health SciencesSurgeryOncology +15

PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer

Steven P. Rowe, Katarzyna J. Macura, Esther Mena, +12

Molecular Imaging and Biology

Positron Emission TomographyMetastatic Prostate CancerUrologyImaging BiomarkersLesion Detection +11

Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working Group

Howard I. Scher, Mario Eisenberger, Anthony V. D’Amico, +21

Journal of Clinical Oncology

Phase I Trial of the Prostate-Specific Membrane Antigen–Directed Immunoconjugate MLN2704 in Patients With Progressive Metastatic Castration-Resistant Prostate Cancer

Matthew D. Galsky, Mario Eisenberger, S. Moore-Cooper, +6

Journal of Clinical Oncology

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

Matthew P. Deek, Kim Van der Eecken, Ryan Phillips, +21

European Urology

Prognostic factors in stage D2 prostate cancer; important implications for future trials: results of a cooperative intergroup study (INT.0036). The National Cancer Institute Intergroup Study #0036.

Mario Eisenberger, Emily Crawford, Margaret C. Wolf, +6

PubMed

Prognostic FactorsUrologyGenitourinary CancerMedicineCooperative Intergroup Study +5

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival of the TAX 327 study

Dominik Berthold, Gregory R. Pond, R deWit, +2

Journal of Clinical Oncology

UrologyOncologyCancer EpidemiologyGenitourinary CancerMedicine +12

Interobserver Variability in Histologic Evaluation of Radical Prostatectomy Between Central and Local Pathologists: Findings of TAX 3501 Multinational Clinical Trial

George J. Netto, Mario Eisenberger, Jonathan I. Epstein

Urology

UrologySurgical OncologyTax 3501Multinational Clinical TrialSurgical Pathology +5

NCCN urothelial cancer practice guidelines. National Comprehensive Cancer Network.

Howard I. Scher, Robert Bahnson, Samuel M. Cohen, +9

PubMed

UrologySurgical OncologyUrologic Cancer EpidemiologyRadiation TherapyGenitourinary Cancer +11